MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects

被引:39
作者
Morita, Y
Sakaeda, T
Horinouchi, M
Nakamura, T
Kuroda, K
Miki, I
Yoshimura, K
Sakai, T
Shirasaka, D
Tamura, T
Aoyama, N
Kasuga, M
Okumura, K
机构
[1] Kobe Univ, Grad Sch Med, Div Diabet Digest & Kidney Dis, Dept Clin Mol Med,Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Kobe Univ, Dept Hosp Pharm, Sch Med, Kobe, Hyogo 6500017, Japan
[3] Kobe Univ, Dept Endoscopy, Sch Med, Kobe, Hyogo 6500017, Japan
关键词
MDR1; polymorphism; digoxin pharmacokinetics; absorption rate; intraduodenal administration;
D O I
10.1023/A:1023282312757
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Recent clinical studies suggest the importance of the MDR1 genotype at position 3435 ( C3435T) in terms of pharmacokinetics, but there is still no consensus in reports on the relationship between the genotype and plasma/ serum concentration - time profiles of drugs after conventional oral administration. This study was performed to elucidate the effects of C3435T on the rate of duodenal absorption of digoxin in healthy Japanese subjects. Methods. Digoxin solution was sprinkled directly over the surface of the duodenum using an endoscope, and its absorption rate was evaluated by serial monitoring of the serum concentration and by analysis of its initial 15- min increasing phase. Results. The duodenal absorption rates of digoxin were 911 +/- 91 ng/ min and 506 +/- 76 ng/ min for C/ C and T/ T, respectively ( +/- SE, p = 0.007). Conclusions. The C3435T mutation of the MDR1 gene is associated with suppression of duodenal absorption of digoxin.
引用
收藏
页码:552 / 556
页数:5
相关论文
共 16 条
[1]   MDR1 pharmacogenetics:: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity [J].
Ameyaw, MM ;
Regateiro, F ;
Li, T ;
Liu, XH ;
Tariq, M ;
Mobarek, A ;
Thornton, N ;
Folayan, GO ;
Githang'a, J ;
Indalo, A ;
Ofori-Adjei, D ;
Price-Evans, DA ;
McLeod, HL .
PHARMACOGENETICS, 2001, 11 (03) :217-221
[2]   Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects [J].
Cascorbi, I ;
Gerloff, T ;
Johne, A ;
Meisel, C ;
Hoffmeyer, S ;
Schwab, M ;
Schaeffeler, E ;
Eichelbaum, M ;
Brinkmann, U ;
Roots, I .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :169-174
[3]   MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine [J].
Drescher, S ;
Schaeffeler, E ;
Hitzl, M ;
Hofmann, U ;
Schwab, M ;
Brinkmann, U ;
Eichelbaum, M ;
Fromm, MF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) :526-534
[4]   Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study [J].
Fellay, J ;
Marzolini, C ;
Meaden, ER ;
Back, DJ ;
Buclin, T ;
Chave, JP ;
Decosterd, LA ;
Furrer, H ;
Opravil, M ;
Pantaleo, G ;
Retelska, D ;
Ruiz, L ;
Schinkel, AH ;
Vernazza, P ;
Eap, CB ;
Telenti, A .
LANCET, 2002, 359 (9300) :30-36
[5]   The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin [J].
Greiner, B ;
Eichelbaum, M ;
Fritz, P ;
Kreichgauer, HP ;
Von Richter, O ;
Zundler, J ;
Kroemer, HK .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :147-153
[6]   Functional polymorphisms of the human multidrug-resistance gene:: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo [J].
Hoffmeyer, S ;
Burk, O ;
von Richter, O ;
Arnold, HP ;
Brockmöller, J ;
Johne, A ;
Cascorbi, I ;
Gerloff, T ;
Roots, I ;
Eichelbaum, M ;
Brinkmann, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3473-3478
[7]   Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677:: Functional relevance to pharmacokinetics of digoxin [J].
Horinouchi, M ;
Sakaeda, T ;
Nakamura, T ;
Morita, Y ;
Tamura, T ;
Aoyama, N ;
Kasuga, M ;
Okumura, K .
PHARMACEUTICAL RESEARCH, 2002, 19 (10) :1581-1585
[8]   Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects [J].
Ito, S ;
Ieiri, I ;
Tanabe, M ;
Suzuki, A ;
Higuchi, S ;
Otsubo, K .
PHARMACOGENETICS, 2001, 11 (02) :175-184
[9]   Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) [J].
Johne, A ;
Brockmöller, J ;
Bauer, S ;
Maurer, A ;
Langheinrich, M ;
Roots, I .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (04) :338-345
[10]   Identification of functionally variant MDR1 alleles among European Americans and African Americans [J].
Kim, RB ;
Leake, BF ;
Choo, EF ;
Dresser, GK ;
Kubba, SV ;
Schwarz, UI ;
Taylor, A ;
Xie, HG ;
McKinsey, J ;
Zhou, S ;
Lan, LB ;
Schuetz, JD ;
Schuetz, EG ;
Wilkinson, GR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (02) :189-199